Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
- PMID: 12895417
- DOI: 10.1016/s0896-6273(03)00434-3
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
Abstract
The neuropathological correlates of Alzheimer's disease (AD) include amyloid-beta (Abeta) plaques and neurofibrillary tangles. To study the interaction between Abeta and tau and their effect on synaptic function, we derived a triple-transgenic model (3xTg-AD) harboring PS1(M146V), APP(Swe), and tau(P301L) transgenes. Rather than crossing independent lines, we microinjected two transgenes into single-cell embryos from homozygous PS1(M146V) knockin mice, generating mice with the same genetic background. 3xTg-AD mice progressively develop plaques and tangles. Synaptic dysfunction, including LTP deficits, manifests in an age-related manner, but before plaque and tangle pathology. Deficits in long-term synaptic plasticity correlate with the accumulation of intraneuronal Abeta. These studies suggest a novel pathogenic role for intraneuronal Abeta with regards to synaptic plasticity. The recapitulation of salient features of AD in these mice clarifies the relationships between Abeta, synaptic dysfunction, and tangles and provides a valuable model for evaluating potential AD therapeutics as the impact on both lesions can be assessed.
Similar articles
-
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.Neurobiol Aging. 2003 Dec;24(8):1063-70. doi: 10.1016/j.neurobiolaging.2003.08.012. Neurobiol Aging. 2003. PMID: 14643377
-
Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.Int J Mol Sci. 2021 Jan 30;22(3):1378. doi: 10.3390/ijms22031378. Int J Mol Sci. 2021. PMID: 33573114 Free PMC article.
-
Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.Neurodegener Dis. 2012;10(1-4):56-9. doi: 10.1159/000334762. Epub 2012 Jan 21. Neurodegener Dis. 2012. PMID: 22269167
-
Alzheimer's disease: Abeta, tau and synaptic dysfunction.Trends Mol Med. 2005 Apr;11(4):170-6. doi: 10.1016/j.molmed.2005.02.009. Trends Mol Med. 2005. PMID: 15823755 Review.
-
[Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].Rev Med Liege. 2007 Apr;62(4):209-16. Rev Med Liege. 2007. PMID: 17566391 Review. French.
Cited by
-
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.Brain. 2012 Dec;135(Pt 12):3735-48. doi: 10.1093/brain/aws289. Epub 2012 Nov 26. Brain. 2012. PMID: 23183235 Free PMC article.
-
Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission.Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672):20140187. doi: 10.1098/rstb.2014.0187. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 26009766 Free PMC article. Review.
-
SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.J Neurosci. 2012 Nov 28;32(48):17262-72. doi: 10.1523/JNEUROSCI.3300-12.2012. J Neurosci. 2012. PMID: 23197718 Free PMC article.
-
Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts.Mol Neurodegener. 2013 Feb 15;8:10. doi: 10.1186/1750-1326-8-10. Mol Neurodegener. 2013. PMID: 23414597 Free PMC article.
-
Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.PLoS One. 2013;8(2):e56426. doi: 10.1371/journal.pone.0056426. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418567 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases